Mobility Shift Assay(MSA)/IMAP™ Kinase Assay QuickScout™ TK Panel ver. 2.0

QuickScout™ TK Panel ver. 2.0 is comprised of 20 Pre-Selected Tyrosine Kinases including both receptor and non-receptor TKs, and is offered to help you rapidly screen your compounds against druggable and clinically relevant tyrosine kinases. Identification and optimization of small molecule inhibitors against many of the targets in our 20 TK Panel including ABL and EGFR has led to the development of first and second generation therapeutics for the treatment of diseases such as leukemia and cancers of the lung, breast, and kidney. The assay ATP concentration can be selected from 1mM or around the Km value. When combined with our STK30 Panel, these pre-selected panel options comprehensively target relevant kinases across the kinome.